PRESS RELEASE FROM ENDPOINTS NEWS

Endpoints News names the Endpoints 11, its list of 2020’s most promising biopharmas — live event to be held today

Posted Sep 30, 2020

Endpoints News this morning published the 2020 Endpoints 11 — its list of the most promising private startups in biotech. Winners will be receiving the Endpoints 11 award today from founder and editor John Carroll at an online event at 4pm ET / 1pm PT. Registration is open at eleven20.endpts.com.

The 2020 Endpoints 11 winners are:

Encoded Therapeutics

insitro

Kronos Bio

Lyell Immunopharma

Orca Bio

Sana Biotechnology

Skyhawk Therapeutics

Sonoma Biotherapeutics

Tessera Therapeutics

Tmunity Therapeutics

Verve Therapeutics

“I chose companies that are swinging for the fences, with teams directing these projects that have the talent, vigor and know how to make it happen. With a pandemic raging, I’m focusing on culture rather than particular assets,” said Carroll. “The Endpoints 11 is a list of companies with a shot at doing something big — or make a hell of a noise if they fail.”

This year’s Endpoints 11 is sponsored exclusively by Catalent. John Chiminski, Catalent’s chairman and CEO, will be presenting the awards to Endpoints 11 winners alongside Endpoints’ John Carroll. A fireside chat with GSK CSO Hal Barron and Lyell founder Rick Klausner will follow.

There is no charge to attend the Endpoints 11, and registration is open to all biopharma professionals at eleven20.endpts.com. The written special report with profiles on each company is available to Endpoints readers with a free Basic subscription at ENDPTS.COM.

“This is a celebration of entrepreneurship,” said Arsalan Arif, Endpoints News founder and publisher. “Building companies these days takes newfound ingenuity, and it’s important to share these stories with everyone.”  

“Thanks to our sponsor, Catalent, and the direct support of Endpoints’ paid subscribers, we’re able to report projects like this, and have plans for more,” Arif added.

 

About Endpoints News

Founded in 2016 by editor John Carroll and publisher Arsalan Arif, Endpoints is an independent news media company with 91,000 daily email subscribers and is available on the web at ENDPTS.COM. There’s no cost for a Basic subscription, which provides readers access to most daily news content and special features like the Endpoints 11. A paid Insider subscription grants access to the entire content library and provides the option for an ad-free experience. And the unlimited-seat Enterprise program gives companies of all sizes access to Endpoints for one flat price. 

Endpoints News has transitioned its global events online and is committed to providing free access for attendees throughout the pandemic. Next week it hosts UKBIO20, convening the UK’s top biotech CEOs and newsmakers for the third consecutive year. And on December 10, Endpoints News hosts Women in Biopharma: 20 of the top women leaders in biopharma R&D 2020. 

 

Press contact: Shelly Whitfield, Operations Director ([email protected])